Robert G. Shulman, Sterling Professor Emeritus of Molecular Biophysics and Biochemistry in Yale's Faculty of Arts and Sciences (FAS) and Yale School ...
Artiva Biotherapeutics is developing NK cell immunotherapy for autoimmune disease. Early trial data in B-cell lymphoma ...
CDK2-mediated TBK1 degradation via Dtx4 represents a previously unrecognized regulatory mechanism that modulates antiviral immunity in fish.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback